A study to Compare the Effect of Mahavasadi Kwath and Pathyadi kwath with Abhijit tail nasayam in paitents with Diabetic Macular Oedema

Comparative Clinical Study To Evaluate The Effect Of Mahavasadi Kwath And Pathyadi Kwath Along With Abhijit Tail Nasayam In Diabetic Macular Oedema (Vataj Timir Roga). - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112706

Enrollment

Registered

2026-06-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H35- Other retinal disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willing to follow the Ayurvedic regimen. 2. Patient between the age group of 30 to 70 years of either sex. 3. Type 2 diabetes mellitus with a history of at least 10 years. 4. Stable blood glucose level. 5. Macular oedema more than 280 m is included.

Exclusion criteria

Exclusion criteria: 1. Patient with ocular manifestation due to serious systemic illness such as carcinoma, CAD (coronary artery disease), chronic renal failure, anemia, and other systemic infections diseases like tuberculosis. 2. Patient with complications after any ophthalmic surgery, such as cataract and glaucoma surgery. 3. Patient with uveitis, branch retinal vein occlusion (BRVO), and central retinal vein occlusion (CRVO), age-related macular degeneration (AMD), retinitis pigmentosa (RP), and vitreomacular traction (VMT). 4. Patient with diabetes taking insulin. 5. Pregnant and lactating women. DME Severe cases (Macular oedema more than 500 m) or those requires urgent surgical interventions are excluded.

Design outcomes

Primary

Measure	Time frame
Subjective Parameters: Blurred vision Metamorphosis (using m-chart) Dark spot Floaters Timepoint: 0, 45, 60, 75, 90 Days	—

Secondary

Measure	Time frame
Objective parameters : Visual acuity Central macular thickness (OCT) Macular volume (OCT) Intraretinal/ subretinal fluid (OCT) Timepoint: 0, 75, 90 Days	—

Countries

India

Contacts

Public ContactDr Vaishanavi Pandey

Patanjali bhartiya ayurvigyan evam anusandhan sansthan, haridwar

jyotiguptania@gmail.com9997907340

Outcome results